Oscar Health, Inc. (NYSE:OSCR) Shares Sold by Versor Investments LP

Versor Investments LP lessened its holdings in shares of Oscar Health, Inc. (NYSE:OSCR) by 39.2% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 22,557 shares of the company’s stock after selling 14,543 shares during the quarter. Versor Investments LP’s holdings in Oscar Health were worth $303,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. KBC Group NV increased its position in Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company’s stock worth $96,000 after buying an additional 2,555 shares during the period. ORG Wealth Partners LLC acquired a new stake in shares of Oscar Health in the 4th quarter worth about $100,000. Alberta Investment Management Corp acquired a new stake in shares of Oscar Health in the 4th quarter worth about $138,000. SMART Wealth LLC bought a new stake in Oscar Health in the 4th quarter valued at about $180,000. Finally, Tempus Wealth Planning LLC acquired a new position in Oscar Health during the 4th quarter valued at about $181,000. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $15.07 on Tuesday. The stock has a market cap of $3.78 billion, a price-to-earnings ratio of -753.12 and a beta of 1.73. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a 12 month low of $12.43 and a 12 month high of $23.79. The stock’s 50 day moving average price is $15.00 and its 200 day moving average price is $16.55.

Oscar Health (NYSE:OSCR) last posted its quarterly earnings data on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a return on equity of 2.28% and a net margin of 0.28%. Equities research analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and dropped their price target for the company from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group initiated coverage on Oscar Health in a research report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 target price on the stock. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.